Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Editas Medicine (EDIT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from experiments to demonstrate expanded CRISPR genome editing strategies in hematopoietic stem cells for...

EDIT : 24.42 (+0.21%)
Editas Medicine, Inc., Announces Pricing of $50 Million Offering of Common Stock

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock. The gross proceeds to Editas Medicine...

MS : 52.64 (-1.02%)
EDIT : 24.42 (+0.21%)
Editas Medicine, Inc., Announces Offering of Common Stock

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it intends to offer and sell $50,000,000 of shares of its common stock in an underwritten public offering. Editas...

MS : 52.64 (-1.02%)
EDIT : 24.42 (+0.21%)
Bitcoin or CRISPR: Which is the Bigger Disruptor?

In just 5 years, two new "exponential technologies" have been created that will dramatically change the world

NVDA : 186.47 (+0.16%)
CRSP : 19.05 (+4.10%)
JPM : 104.66 (-0.81%)
EDIT : 24.42 (+0.21%)
CME : 150.42 (-0.78%)
MGTI : 3.8100 (-3.79%)
AMZN : 1,174.26 (+0.87%)
Don't Fight the Gravity of Exponential Change

Technology is reshaping life and business so fast that intelligent adaptation could be the #1 skill of the 21st century.

NVDA : 186.47 (+0.16%)
AAPL : 172.22 (-0.03%)
CRSP : 19.05 (+4.10%)
CYBR : 43.00 (-1.13%)
EDIT : 24.42 (+0.21%)
FEYE : 14.30 (+2.51%)
SWKS : 94.09 (-1.85%)
Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed(TM) Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team

Torque, an immuno-oncology company developing Deep Primed(TM) cell therapies that direct and evoke immune responses in the tumor microenvironment, today announced the launch of its technology platform...

SYRS : 8.98 (-1.10%)
MCRB : 9.84 (-2.38%)
RYTM : 28.04 (+3.35%)
EDIT : 24.42 (+0.21%)
MACK : 10.18 (-1.64%)
Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team

CAMBRIDGE, Mass. , Nov. 14, 2017 /PRNewswire/ -- Torque, an immuno-oncology company developing Deep Primed™ cell therapies that direct and evoke immune responses in the tumor microenvironment,...

SYRS : 8.98 (-1.10%)
MCRB : 9.84 (-2.38%)
RYTM : 28.04 (+3.35%)
EDIT : 24.42 (+0.21%)
MACK : 10.18 (-1.64%)
mHealth and Telemedicine Innovation Vastly Improving Healthcare Services for Patients

PALM BEACH, Florida, November 9, 2017 /PRNewswire/ --

SGMO : 16.40 (-0.61%)
RHT.VN : 1.220 (-5.43%)
RQHTF : 0.9152 (-10.27%)
ARRY : 11.12 (-3.22%)
EDIT : 24.42 (+0.21%)
THC : 14.06 (-5.13%)
mHealth and Telemedicine Innovation Vastly Improving Healthcare Services for Patients

Telemedicine and mHealth services, apps and platforms are increasingly gaining a foothold over traditional healthcare as a result of the rising use of telecommunication to deliver innovative healthcare...

SGMO : 16.40 (-0.61%)
RHT.VN : 1.220 (-5.43%)
RQHTF : 0.9152 (-10.27%)
ARRY : 11.12 (-3.22%)
EDIT : 24.42 (+0.21%)
THC : 14.06 (-5.13%)
Editas Medicine Announces Third Quarter 2017 Results and Update

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today reported financial results for the third quarter ended September 30, 2017, and provided an update on recent achievements and...

EDIT : 24.42 (+0.21%)
What's in the Cards for Adverum (ADVM) This Earnings Season?

Adverum Biotechnologies (ADVM) will report its third-quarter results later this month. Investors focus is expected to be on pipeline updates.

ADVM : 3.10 (unch)
EDIT : 24.42 (+0.21%)
ACAD : 28.97 (-3.24%)
REGN : 383.12 (-0.92%)
Editas Medicine to Host Conference Call Discussing Third Quarter 2017 Corporate Update and Results

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, November 7, 2017, at 5:00 p.m. ET to discuss a corporate...

EDIT : 24.42 (+0.21%)
Telemedicine Innovation Changing the Landscape of Traditional Healthcare

PALM BEACH, Florida, November 2, 2017 /PRNewswire/ --

KND : 8.15 (-4.68%)
SGMO : 16.40 (-0.61%)
RHT.VN : 1.220 (-5.43%)
RQHTF : 0.9152 (-10.27%)
ACHN : 2.89 (unch)
EDIT : 24.42 (+0.21%)
Telemedicine Innovation Changing the Landscape of Traditional Healthcare

Telemedicine is increasingly gaining popularity over traditional healthcare owing to the rising use of telecommunication to deliver various healthcare services to patients. The telemedicine market in the...

SGMO : 16.40 (-0.61%)
KND : 8.15 (-4.68%)
RHT.VN : 1.220 (-5.43%)
RQHTF : 0.9152 (-10.27%)
ACHN : 2.89 (unch)
EDIT : 24.42 (+0.21%)
Editas Medicine Demonstrates Dose-Dependent, In Vivo Editing with EDIT-101 in CEP290 Transgenic Mice

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from a pre-clinical study in transgenic mice demonstrating dose-dependent, in vivo editing using EDIT-101,...

EDIT : 24.42 (+0.21%)
Editas Medicine to Participate in Investor Conferences in October

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in New York in October. Details are as follows:...

EDIT : 24.42 (+0.21%)
Another Positive Week for Stocks?

Another Positive Week for Stocks?

CRR : 9.73 (-1.02%)
BLUE : 184.35 (-0.30%)
EDIT : 24.42 (+0.21%)
ABBV : 96.30 (-1.08%)
EPZM : 12.60 (-4.91%)
Editas Medicine Receives EMA's Orphan Medicinal Product Designation for EDIT-101 for the Treatment of LCA10

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the European Medicines Agency (EMA) granted Orphan Medicinal Product designation to EDIT-101, a pre-clinical, CRISPR-based...

EDIT : 24.42 (+0.21%)
Flagship Pioneering Unveils Kaleido Biosciences and First Chemistry Platform for Microbiome Health

Flagship Pioneering, a fully-integrated life science innovation enterprise, today unveiled Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries that unlock the power...

SYRS : 8.98 (-1.10%)
AGIO : 52.37 (-4.78%)
MCRB : 9.84 (-2.38%)
EDIT : 24.42 (+0.21%)
Biotech Stocks on Investors' Radar -- Clovis Oncology, Dermira, Editas Medicine, and Endocyte

If you want a Stock Review on CLVS, DERM, EDIT, or ECYT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Thursday, September 14, 2017, US markets...

DERM : 26.63 (-3.20%)
CLVS : 64.14 (+0.58%)
ECYT : 4.61 (-1.91%)
EDIT : 24.42 (+0.21%)

Van Meerten Stock Picks

5 Great Mid Caps
  Today you will find that I have varied a little bit from my usual search criteria.
KBH +0.10 , IPGP +0.48 , FSLR -0.59 , NVR +35.54 , TTWO +1.28
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.07%) this morning are up +0.07% on increased optimism in the U.S. economic outlook after the Fed yesterday raised its U.S. 2018 GDP estimate to 2.5% from 2.1% and said it still didn't see... Read More

Chart of the Day

Chart of the Day

Nexstar Broadcasting (NXST) is the Barchart Chart of the Day.  The TV media company has a Trend Spotter buy signal, a Weighted Alpha of 25.66+ and gained 16.41% in the last month.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed the day with most contracts fractionally in the red, after spending much of the morning fractionally higher. The daily range was microscopic! This morning’s USDA Export Sales report showed 866,918 MT in corn sales for the we...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.